| Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants. F Couch, H Huang, T Pesaran, R Karam, S Yadav, SM Domchek, ... Journal of Clinical Oncology 42 (16_suppl), 10511-10511, 2024 | | 2024 |
| Pan-cancer analysis identifies signatures of HRD-positivity in germline BRCA1/2 mutated non-BRCA associated cancers DM Muldoon, M Mehine, S Tischfield, AR Brannon, M Ladanyi, ZK Stadler, ... Cancer Research 84 (6_Supplement), 1757-1757, 2024 | | 2024 |
| Signatures of selection for biallelic inactivation in tumor suppressor genes across cancer types MR Zucker, MA Perry, A Elkrief, A Safonov, R Thummalapalli, SI Gould, ... Cancer Research 84 (6_Supplement), 1202-1202, 2024 | | 2024 |
| Emerging disparities in the clinical actionability landscape for patients with inferred African ancestry K Arora, SP Suehnholz, H Zhang, R Kundra, S Nandakumar, M Nissan, ... Cancer Research 84 (6_Supplement), 6129-6129, 2024 | | 2024 |
| HLA genotyping and HLA-based clinical trial matching using MSK-IMPACT, a targeted next-generation sequencing assay MF Chen, MV Gormally, AM Noronha, K Panageas, M Reynolds, ... Cancer Research 84 (6_Supplement), 6570-6570, 2024 | | 2024 |
| Genomic ancestry in kidney cancer: Correlations with clinical and molecular features RR Kotecha, A Knezevic, K Arora, C Bandlamudi, F Kuo, MI Carlo, ... Cancer 130 (5), 692-701, 2024 | 1 | 2024 |
| Pathogenic germline variants in patients with endometrial cancer of diverse ancestry YL Liu, S Gordhandas, K Arora, E Rios‐Doria, KA Cadoo, A Catchings, ... Cancer 130 (4), 576-587, 2024 | 4 | 2024 |
| Abstract C074: Clinico-genomic characterization of N=2,460 pancreatic adenocarcinoma identifies KRASMUT dosage as prognostic of overall survival across … AM Varghese, MA Perry, D Muldoon, S Nandakumar, A Erakky, B Nguyen, ... Cancer Research 84 (2_Supplement), C074-C074, 2024 | | 2024 |
| Abstract B045: Deep genomic and single cell molecular profiles define immunogenic pancreatic cancer W Park, S Umeda, C O'Connor, H Zhang, R Sharma, A Richards, Y Zhu, ... Cancer Research 84 (2_Supplement), B045-B045, 2024 | | 2024 |
| Clinico-genomic characterization of N= 2,460 pancreatic adenocarcinoma identifies KRASMUT dosage as prognostic of overall survival across disease stages AM Varghese, MA Perry, D Muldoon, S Nandakumar, A Erakky, B Nguyen, ... CANCER RESEARCH 84 (2), 2024 | | 2024 |
| Homologous recombination deficiency and tumor suppressor heterozygosity mediate resistance to front-line therapy in breast cancer A Safonov, A Marra, C Bandlamudi, B O'Leary, B Wubbenhorst, E Moiso, ... bioRxiv, 2024.02. 05.578934, 2024 | | 2024 |
| Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer R Thummalapalli, B Ricciuti, C Bandlamudi, D Muldoon, H Rizvi, A Elkrief, ... Clinical Cancer Research 29 (21), 4408-4418, 2023 | 5 | 2023 |
| 2231O Pan-cancer assessment of the impact of intronic variants on cancer development and progression A Safonov, M Mehine, O Ceyhan-Birsoy, D Brown, C Bandlamudi, ... Annals of Oncology 34, S1149, 2023 | | 2023 |
| Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade EC Harrold, MB Foote, B Rousseau, H Walch, Y Kemel, AL Richards, ... Nature Medicine 29 (10), 2458-2463, 2023 | 5 | 2023 |
| Germline pathogenic variants and genetic counseling by ancestry in patients with epithelial ovarian cancer TY Sia, A Maio, YM Kemel, KS Arora, SB Gordhandas, RM Kahn, ... JCO Precision Oncology 7, e2300137, 2023 | 2 | 2023 |
| Associations between cancer predisposition mutations and clonal hematopoiesis in patients with solid tumors S Franch-Expósito, M Mehine, RN Ptashkin, KL Bolton, C Bandlamudi, ... JCO Precision Oncology 7, e2300070, 2023 | 4 | 2023 |
| Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non–Small Cell Lung Cancer B Ricciuti, A Elkrief, J Alessi, X Wang, Y Li, H Gupta, DM Muldoon, ... Clinical Cancer Research 29 (13), 2540-2550, 2023 | 4 | 2023 |
| POT1 germline pathogenic variants and evolving understanding of tumor spectrum: Evidence for lung cancer predisposition. MF Walsh, S Mukherjee, M Gao, E Fiala, A Mauguen, Y Kemel, ... Journal of Clinical Oncology 41 (16_suppl), 10511-10511, 2023 | | 2023 |
| Pathogenic germline variants in patients with endometrial cancer across diverse ancestries. YL Liu, S Gordhandas, K Arora, A Maio, Y Kemel, M Sheehan, ... Journal of Clinical Oncology 41 (16_suppl), 5596-5596, 2023 | | 2023 |
| Ancestry-adjusted genomic analysis to identify known and novel associations with single and multiple cancer phenotypes. V Joseph, V Ravichandran, I Ostrovnaya, YL Liu, K Tkachuk, A Khurram, ... Journal of Clinical Oncology 41 (16_suppl), 10504-10504, 2023 | | 2023 |
